Search Results for: Schizophrenia

1632 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
PPP2R2B and TP53 protein phosphatase 2, regulatory subunit B, beta tumor protein p53
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
TP53 and FBXO11 tumor protein p53 F-box protein 11
  • Cellular Senescence
  • Activation of BH3-only proteins
  • p53-Dependent G1/S DNA damage checkpoint
  • Oncogene Induced Senescence
  • p53-Dependent G1 DNA Damage Response
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Pre-NOTCH Transcription and Translation
  • Stabilization of p53
  • Transcriptional activation of p53 responsive genes
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • G1/S DNA Damage Checkpoints
  • Intrinsic Pathway for Apoptosis
  • Transcriptional activation of cell cycle inhibitor p21
  • DNA Damage/Telomere Stress Induced Senescence
  • Signaling by NOTCH
  • Factors involved in megakaryocyte development and platelet production
  • Activation of NOXA and translocation to mitochondria
  • Oxidative Stress Induced Senescence
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Activation of PUMA and translocation to mitochondria
  • Cell Cycle Checkpoints
CDKN2A and RIN2 cyclin-dependent kinase inhibitor 2A Ras and Rab interactor 2
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
MYC and SMARCA2 v-myc avian myelocytomatosis viral oncogene homolog SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
  • Loss of Function of TGFBR2 in Cancer
  • Signaling by NOTCH1 HD Domain Mutants in Cancer
  • Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • Signaling by Wnt
  • Cyclin E associated events during G1/S transition
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • TGFBR1 LBD Mutants in Cancer
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
  • Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
  • Generic Transcription Pathway
  • RNF mutants show enhanced WNT signaling and proliferation
  • G1/S Transition
  • Signaling by NOTCH1
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by NOTCH1 in Cancer
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • Mitotic G1-G1/S phases
  • FBXW7 Mutants and NOTCH1 in Cancer
  • TGFBR2 MSI Frameshift Mutants in Cancer
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Loss of Function of SMAD2/3 in Cancer
  • Signaling by NOTCH
  • formation of the beta-catenin:TCF transactivating complex
  • TGFBR2 Kinase Domain Mutants in Cancer
  • Loss of Function of SMAD4 in Cancer
  • TGFBR1 KD Mutants in Cancer
  • S Phase
  • Cell Cycle, Mitotic
  • Loss of Function of TGFBR1 in Cancer
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Signaling by TGF-beta Receptor Complex in Cancer
  • Signaling by TGF-beta Receptor Complex
  • TCF dependent signaling in response to WNT
  • Signaling by NOTCH1 PEST Domain Mutants in Cancer
  • Cyclin A:Cdk2-associated events at S phase entry
  • Signaling by WNT in cancer
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • SMAD4 MH2 Domain Mutants in Cancer
  • Chromatin modifying enzymes
  • Chromatin organization
  • RMTs methylate histone arginines
LMNA and SYNE1 lamin A/C spectrin repeat containing, nuclear envelope 1
  • IRE1alpha activates chaperones
  • XBP1(S) activates chaperone genes
  • Unfolded Protein Response (UPR)
  • Meiotic synapsis
ERBB2 and RIN2 erb-b2 receptor tyrosine kinase 2 Ras and Rab interactor 2
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • Axon guidance
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • SHC1 events in ERBB2 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Sema4D in semaphorin signaling
  • Sema4D induced cell migration and growth-cone collapse
  • Innate Immune System
  • Signaling by PDGF
  • Downregulation of ERBB2:ERBB3 signaling
  • Signalling by NGF
  • DAP12 interactions
  • GAB1 signalosome
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by ERBB4
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by FGFR
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Trastuzumab
  • Lapatinib
  • ado-trastuzumab emtansine
  • Pertuzumab
  • Afatinib
ERBB2 and ANKS1B erb-b2 receptor tyrosine kinase 2 ankyrin repeat and sterile alpha motif domain containing 1B
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by FGFR in disease
  • Axon guidance
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • SHC1 events in ERBB2 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • DAP12 signaling
  • PI3K/AKT activation
  • PI-3K cascade
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Sema4D in semaphorin signaling
  • Sema4D induced cell migration and growth-cone collapse
  • Innate Immune System
  • Signaling by PDGF
  • Downregulation of ERBB2:ERBB3 signaling
  • Signalling by NGF
  • DAP12 interactions
  • GAB1 signalosome
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by ERBB4
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Constitutive PI3K/AKT Signaling in Cancer
  • PI3K events in ERBB4 signaling
  • Signaling by FGFR
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Trastuzumab
  • Lapatinib
  • ado-trastuzumab emtansine
  • Pertuzumab
  • Afatinib
EGFR and RIN2 epidermal growth factor receptor Ras and Rab interactor 2
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PI3K/AKT activation
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by PDGF
  • EGFR downregulation
  • DAP12 interactions
  • GAB1 signalosome
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Axon guidance
  • PIP3 activates AKT signaling
  • L1CAM interactions
  • EGFR Transactivation by Gastrin
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Innate Immune System
  • Signalling by NGF
  • Signal transduction by L1
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Inhibition of Signaling by Overexpressed EGFR
  • Signaling by FGFR
  • SHC1 events in EGFR signaling
  • Constitutive Signaling by EGFRvIII
  • Cetuximab
  • Trastuzumab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Flavopiridol
  • Vandetanib
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • Afatinib
ANXA1 and EGFR annexin A1 epidermal growth factor receptor
  • G alpha (q) signalling events
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • Class A/1 (Rhodopsin-like receptors)
  • GPCR ligand binding
  • Metabolic disorders of biological oxidation enzymes
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • G alpha (q) signalling events
  • GPCR downstream signaling
  • Peptide ligand-binding receptors
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • G alpha (i) signalling events
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PI3K/AKT activation
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by PDGF
  • EGFR downregulation
  • DAP12 interactions
  • GAB1 signalosome
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Axon guidance
  • PIP3 activates AKT signaling
  • L1CAM interactions
  • EGFR Transactivation by Gastrin
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Innate Immune System
  • Signalling by NGF
  • Signal transduction by L1
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Inhibition of Signaling by Overexpressed EGFR
  • Signaling by FGFR
  • SHC1 events in EGFR signaling
  • Constitutive Signaling by EGFRvIII
  • Amcinonide
  • Hydrocortisone
  • Dexamethasone
  • Cetuximab
  • Trastuzumab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Flavopiridol
  • Vandetanib
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • Afatinib
EGFR and ANKS1B epidermal growth factor receptor ankyrin repeat and sterile alpha motif domain containing 1B
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Signaling by FGFR in disease
  • Signaling by EGFRvIII in Cancer
  • PLCG1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • Signaling by SCF-KIT
  • DAP12 signaling
  • Downstream signaling events of B Cell Receptor (BCR)
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PI3K/AKT activation
  • PI-3K cascade
  • Gastrin-CREB signalling pathway via PKC and MAPK
  • Signaling by PDGF
  • EGFR downregulation
  • DAP12 interactions
  • GAB1 signalosome
  • GRB2 events in EGFR signaling
  • Signaling by ERBB4
  • Constitutive PI3K/AKT Signaling in Cancer
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • PI3K events in ERBB4 signaling
  • EGFR interacts with phospholipase C-gamma
  • Signaling by ERBB2
  • Signaling by EGFR
  • Downstream signal transduction
  • Signaling by EGFR in Cancer
  • Fc epsilon receptor (FCERI) signaling
  • PI3K/AKT Signaling in Cancer
  • Adaptive Immune System
  • Axon guidance
  • PIP3 activates AKT signaling
  • L1CAM interactions
  • EGFR Transactivation by Gastrin
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Downstream signaling of activated FGFR
  • Innate Immune System
  • Signalling by NGF
  • Signal transduction by L1
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Inhibition of Signaling by Overexpressed EGFR
  • Signaling by FGFR
  • SHC1 events in EGFR signaling
  • Constitutive Signaling by EGFRvIII
  • Cetuximab
  • Trastuzumab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Flavopiridol
  • Vandetanib
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • Afatinib
HLA-DMA and HLA-DRB1 major histocompatibility complex, class II, DM alpha major histocompatibility complex, class II, DR beta 1
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
CTAG1B and HLA-DRB1 cancer/testis antigen 1B major histocompatibility complex, class II, DR beta 1
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRA and HLA-DRB1 major histocompatibility complex, class II, DR alpha major histocompatibility complex, class II, DR beta 1
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and MAGEA3 major histocompatibility complex, class II, DR beta 1 melanoma antigen family A, 3
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and MARCH1 major histocompatibility complex, class II, DR beta 1 membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and TRA major histocompatibility complex, class II, DR beta 1 T cell receptor alpha locus
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and TRB major histocompatibility complex, class II, DR beta 1 T cell receptor beta locus
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
HLA-DRB1 and TRIM21 major histocompatibility complex, class II, DR beta 1 tripartite motif containing 21
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Interferon gamma signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Regulation of innate immune responses to cytosolic DNA
  • Cytosolic sensors of pathogen-associated DNA
  • STING mediated induction of host immune responses
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Class I MHC mediated antigen processing & presentation
  • Innate Immune System
  • Adaptive Immune System
HLA-DRB1 and ZDHHC17 major histocompatibility complex, class II, DR beta 1 zinc finger, DHHC-type containing 17
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
  • Generation of second messenger molecules
  • Downstream TCR signaling
  • Costimulation by the CD28 family
  • Translocation of ZAP-70 to Immunological synapse
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Interferon gamma signaling
  • TCR signaling
  • MHC class II antigen presentation
  • PD-1 signaling
  • Phosphorylation of CD3 and TCR zeta chains
  • Adaptive Immune System
CTNNB1 and TCF4 catenin (cadherin-associated protein), beta 1, 88kDa transcription factor 4
  • APC truncation mutants have impaired AXIN binding
  • misspliced GSK3beta mutants stabilize beta-catenin
  • T41 mutants of beta-catenin aren't phosphorylated
  • TCF7L2 mutants don't bind CTBP
  • truncated APC mutants destabilize the destruction complex
  • Signaling by Wnt
  • binding of TCF/LEF:CTNNB1 to target gene promoters
  • deactivation of the beta-catenin transactivating complex
  • APC truncation mutants are not K63 polyubiquitinated
  • disassembly of the destruction complex and recruitment of AXIN to the membrane
  • S37 mutants of beta-catenin aren't phosphorylated
  • Degradation of beta-catenin by the destruction complex
  • AXIN mutants destabilize the destruction complex, activating WNT signaling
  • RNF mutants show enhanced WNT signaling and proliferation
  • S33 mutants of beta-catenin aren't phosphorylated
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Innate Immune System
  • truncations of AMER1 destabilize the destruction complex
  • CDO in myogenesis
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • Cytosolic sensors of pathogen-associated DNA
  • formation of the beta-catenin:TCF transactivating complex
  • phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
  • AXIN missense mutants destabilize the destruction complex
  • S45 mutants of beta-catenin aren't phosphorylated
  • repression of WNT target genes
  • beta-catenin independent WNT signaling
  • deletions in the AMER1 gene destabilize the destruction complex
  • Ca2+ pathway
  • Myogenesis
  • AMER1 mutants destabilize the destruction complex
  • TCF dependent signaling in response to WNT
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
  • Signaling by WNT in cancer
  • CDO in myogenesis
  • Myogenesis
  • Urea

Page 1 out of 82 pages